Current clinical management of dysfunctional bioprosthetic pulmonary valves. (2nd January 2020)

• Record Type: Journal Article
• Authors: Aggarwal, Varun; Spigel, Zachary A; Hiremath, Gurumurthy; Binsalamah, Ziyad; Qureshi, Athar M
• Is Part Of: Expert review of cardiovascular therapy. Volume 18:Number 1(2020)
• Page Start: 7
• Page End: 16
• Publication Date: 2020-01-02
• Subjects: Bioprosthetic -- pulmonary valve -- surgical bioprosthetic pulmonary valve placement -- transcatheter pulmonary valve -- intentional frame fracture; Cardiovascular agents -- Research -- Periodicals; 616.12061
• DOI: 10.1080/14779072.2020.1715796
• Languages: English
• ISSNs: 1477-9072

Abstract

ABSTRACT: Introduction : As with any bioprosthetic valve, bioprosthetic valves in the pulmonary position have a finite life span and patients with bioprosthetic pulmonary valves require lifetime management to treat valve dysfunction. Areas covered : In this article, authors discuss the current medical management for the treatment of dysfunctional bioprosthetic valves. This review is based on both an extensive review of the recent cardiac surgical/interventional cardiology literature (PubMed and MEDLINE database searches from 1958 to 2019) and personal experience. Expert opinion : Valve technology is rapidly progressing and with a coordinated effort from cardiac surgeons and interventional cardiologists, patients suffering from bioprosthetic pulmonary valve dysfunction can expect to have a decreased number of procedures and less invasive procedures over their lifetime now.